Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
出版年份 2017 全文链接
标题
Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
作者
关键词
<em class=EmphasisTypeItalic >ALK</em>, <em class=EmphasisTypeItalic >ALK</em> fusions, NanoString, FFPE
出版物
BMC Pulmonary Medicine
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-26
DOI
10.1186/s12890-017-0428-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
- (2017) Toni-Maree Rogers et al. Scientific Reports
- Second- and third-generation ALK inhibitors for non-small cell lung cancer
- (2016) Jingjing Wu et al. Journal of Hematology & Oncology
- Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
- (2016) Ibiayi Dagogo-Jack et al. ONCOLOGIST
- Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK -Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
- (2016) Siraj M. Ali et al. ONCOLOGIST
- A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
- (2015) Frederick H. Wilson et al. CANCER CELL
- KIAA1549
- (2015) Aline Paixão Becker et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)
- (2015) Alessandra Cesano Journal for ImmunoTherapy of Cancer
- Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
- (2014) Kate McKeage DRUGS
- An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators
- (2014) Murry W. Wynes et al. Journal of Thoracic Oncology
- Variants on a Theme: A Biomarker of Crizotinib Response in ALK-Positive Non-Small Cell Lung Cancer?
- (2012) A. S. Crystal et al. CLINICAL CANCER RESEARCH
- Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
- (2012) J. M. Heuckmann et al. CLINICAL CANCER RESEARCH
- Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer
- (2012) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities
- (2011) Elizabeth M. Gaughan et al. Therapeutic Advances in Medical Oncology
- Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
- Inhibition of ALK Signaling for Cancer Therapy
- (2009) Y. P. Mosse et al. CLINICAL CANCER RESEARCH
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
- (2009) K. Takeuchi et al. CLINICAL CANCER RESEARCH
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started